Catalyst Wire Dossier Catalyst Wire Dossier

Fexofenadine HCl + Pseudoephedrine HCl Fixed-Dose Combination

fexofenadine hydrochloride; pseudoephedrine hydrochloride · Sanofi
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fexofenadine HCl + Pseudoephedrine HCl Fixed-Dose Combination, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above [Phase 4]

See pricing